← Back to headlines
Co-Diagnostics Aims for India TB Test Commercialization by Q3 2026
Co-Diagnostics anticipates the commercialization of its tuberculosis test in India by the third quarter of 2026, while also exploring SPAC options for its CoSara venture.
1 Apr, 06:43 — 1 Apr, 06:43
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk
just now
Philippine DICT Urges Meta to Strengthen Fake News Safeguards
just now
Artemis II Mission Becomes Focus of AI-Driven Disinformation and Moon Landing Conspiracy Theories
just now
Iran's Untraced Naval Mines in Strait of Hormuz Pose Detection Challenge
15m ago